Approximately 1 in 7 Australians are antidepressant users. The choice to begin is frequently taken during a crisis, with the idea that they might provide assistance temporarily before ceasing. Most people don’t begin antidepressant medication with the intention of using it forever.
On the other hand, more than half of antidepressant users had been taking them for more than a year. When people try to stop taking antidepressants, they may have unpleasant withdrawal symptoms, which makes them want to start taking them again or keep taking them.
According to the Lancet analysis, which comprised 21,000 participants and 79 studies, 15% of antidepressant users had withdrawal symptoms when they stopped taking the medication. Dizziness, headaches, nausea, sleeplessness, and irritability were common complaints.
Individuals taking antidepressants for an extended period of time are more likely to have withdrawal symptoms. However, the majority of participants in the Lancet trial were taking antidepressants for a brief period of time, typically three to six months, though occasionally for as little as one week.
According to the Lancet review, approximately 3% of participants reported having severe withdrawal symptoms, including suicidal thoughts. Once more, this is probably an underestimate because longer-term users are more likely to have more severe withdrawal symptoms and to experience them at all.
determining the true cause of the symptoms
Because anxiety and depression symptoms are so similar, some people continue taking antidepressants for a long time under the mistaken impression that they are treating or preventing these conditions. In reality, however, they may merely be treating or preventing withdrawal symptoms. Nevertheless, using antidepressants for more than a year does not guarantee safety.
Up until recently, there was little information available on how to lessen withdrawal symptoms so that antidepressant users might quit taking them safely.
In the past, it was common advise to cut the dosage in half, cut it again, and eventually cease; alternatively, to take antidepressants on separate days; or to switch to an alternative antidepressant.
Nevertheless, despite their good intentions, these techniques have probably led to withdrawal symptoms.
Brain imaging methods facilitate a gradual reduction in the dosage of antidepressant medications to provide a gradual alteration in the brain and lessen the symptoms of withdrawal.
“Hyperbolic tapering” involves progressively smaller dosage reductions of medication. A tapering plan of, say, 50 mg, 25 mg, 15 mg, 10 mg, 6 mg, 4 mg, 2 mg, 1 mg, and finally 0 mg (halt) results in a consistent shift in the brain.
Clinical guidelines that have been updated now advocate for this excessively slow weaning off of antidepressants.
Our randomized controlled trial in general practise at the University of Queensland is evaluating the efficacy of hyperbolic tapering plans tailored to antidepressant drugs, which are intended to help people safely wean themselves off of them.
In Australia, antidepressant mini-doses that are necessary for tapering are not easily accessible. However, people can obtain tiny dosages of antidepressants through a compounding chemist (or, in the case of some antidepressants, by smashing a tablet and diluting a liquid formulation, after consulting with your physician).
